Workflow
叶酸等维生素类产品
icon
Search documents
圣达生物股价微跌0.75% 公司完成8000万元理财赎回
Jin Rong Jie· 2025-08-18 20:08
Group 1 - The stock price of Shengda Bio reported at 18.64 yuan as of August 18, 2025, with a decrease of 0.14 yuan, representing a decline of 0.75% from the previous trading day [1] - The company specializes in the research, production, and sales of biotin, folic acid, and other vitamin products, which are widely used in feed, food, and pharmaceutical industries [1] - Shengda Bio's industry classification falls under the chemical products sector, involving synthetic biology and vitamins concepts [1] Group 2 - Shengda Bio announced the redemption of structured deposits amounting to 80 million yuan, which matured on August 15, resulting in a total recovery of 80.1193 million yuan, aligning with expected returns [1] - On August 18, the net outflow of main funds was 6.7311 million yuan, with a cumulative net outflow of 17.9616 million yuan over the past five days [1]
圣达生物股价微跌0.49% 中报预增超112%引关注
Jin Rong Jie· 2025-08-05 19:06
消息面上,圣达生物预计2025年1-6月归属于上市公司股东的净利润为3500万元至4500万元,同比增长 112.19%至172.81%。 资金流向方面,8月5日主力资金净流出1687.95万元,近五日累计净流出3778.23万元。 风险提示:市场有风险,投资需谨慎。 截至2025年8月5日收盘,圣达生物股价报18.35元,较前一交易日下跌0.49%,成交额0.77亿元,换手率 2.44%。 圣达生物主营业务为生物素、叶酸等维生素类产品的研发、生产和销售,产品广泛应用于饲料、食品、 医药等领域。公司所属板块包括化学制品、合成生物、维生素等。 ...